Mergers & acquisitions once again took center stage in the biotech sector with Alexion (ALXN – Analyst Report) announcing its intention to acquire Synageva (GEVA – Snapshot Report). Meanwhile, there were some important updates on the regulatory and pipeline front from companies like Vertex (VRTX – Analyst Report) and Orexigen (OREX – Analyst Report).Recap of the Week’s Most Important Stories1. […]
Ruchir Sharma argues in today’s WSJ (“The Federal Reserve Asset Bubble Machine”) that the Fed’s easy money policies have created dangerous asset market bubbles in “stocks … bonds, houses and every other financial asset.” In particular, he claims that his “composite valuation for the three major financial assets in America—stocks, bonds and houses—is currently well above levels reached during the […]
BEIJING (AP) — Major Asian stocks markets were muted Wednesday after a bond sell-off nudged Wall Street lower.KEEPING SCORE: The Shanghai Composite Index was little changed at 4,400.28 and Tokyo’s Nikkei 225 was steady at 19,615.55. Hong Kong’s Hang Seng was stable at 27,423.29. Seoul’s Kospi gained 0.7 percent to 2,112.37 and Sydney’s S&P/ASX 200 was up 0.5 percent at […]
I found some very interesting information when conducting research on small-cap biotech stocks. Most disturbing: Well-respected analysts recommended an abundance of small-cap biotech stocks that have since been annihilated. My job is to give readers ideas where they can start research to not only potentially make money, but to stay away from dangerous names. It’s not going to do any […]
Vivek Ramaswamy
Just before Christmas last year, a newly formed Bermuda-based biotech run by former hedge fund partner Vivek Ramaswamy struck a deal to in-license a shelved Alzheimer’s drug from GlaxoSmithKline ($GSK) with plans to put it into Phase III. That late-stage study won’t start until the fourth quarter, but the newborn biotech isn’t waiting around at the starting line. The […]
Will one month’s manufacturing data really prompt the Bank of England to raise rates? Photograph: ANDY RAIN/EPA
Financial markets can be utterly perverse. To any normal person, news that industrial production recovered in March would be seen as good news, tentative evidence that the economy is emerging from a soft patch in early 2015.But not if you are someone dealing in […]
TraderFeed: Where is Weakness Coming From in the Stock Market?
Where is Weakness Coming From in the Stock Market?It’s interesting to note that, according to the excellent screening tools at FinViz, the three U.S. stock market sectors that have been down over the prior two quarters have been Conglomerates, Basic Materials, and Utilities (top chart). Those are also the highest yielding […]
Talk Of A Stock Market Crash – How Concerned Should We Be?By: Chris Ciovacco | Mon, May 11, 2015SharePrintEmailA MarketWatch opinion piece published on 05/11/15 has the attention-grabbing headline “Countdown to the stock market Crash of 2016 is ticking louder”.How often have calls for a crash been made in recent years? While we will not attempt to answer the question […]
The trend is your friend…You’ve heard that one before. Everyone has. Why is it so famous?Simple: Markets trend. Period. It doesn’t matter if you’re a value investor, daytrader, swing trader, or stargazer– you can’t deny this simple truth.Today I’m going to show you how you can use a trending market to your advantage—but also what to do when the trend […]
Tesla Motors acquired Riviera Tool LLC, a tool and die company based out of Michigan, for an undisclosed sum on the 7th of May. What followed was a buying frenzy of the wrong stock, which led to the industry regulator stepping in.Not long after the acquisition announcement by Tesla Motors, stock speculators suggested that shares in Riviera Tool LLC would be a good purchase, […]
